Abstract
Hyperferritinemia (>10,000 ng/ml) is an important hallmark used as an indicator of infection triggered macrophage activation syndrome leading to hemophagocytic lympho histiocytosis (HLH). Measurement of serum ferritin can be used in diagnosis as well as disease monitoring indicator and prognosis related to HLH, cAPS, sepsis, neoplasm and inflammatory conditions. It is a major contributor to manage critically ill patients as predicting and monitoring indicator. It can be used as acute phase response in conditions of MAS, AOSD, cAPS etc. A case study in our hospital showed extremely high ferritin values along with low hemoglobin, elevated LDH and triglycerides with positive MRSA in sputum culture and macrophage proliferation and hemophagocytosis in the bone marrow examination. Patient showed definite inverse relation with steroid therapy and serum ferritin levels.
Electronic supplementary material
The online version of this article (doi:10.1007/s12291-016-0559-8) contains supplementary material, which is available to authorized users.
Introduction
Hyperferritinemia (>10,000 ng/ml) is an important hallmark for using as an indicator of activity of phagocytic function of macrophages in hemophagocytic lympho histiocytosis (HLH)/macophage activation syndrome (MAS).
Ferritin is a 24 subunit major intracellular iron storage protein. Within the cytosol it stores iron in a non soluble non toxic form and so protecting the cell. In the circulation it acts as delivery mechanism and its serum level reflect total iron body store [1]. It can be elevated in wide range of conditions such as malignancy, infection, septic shock, inflammation and chronic iron overload syndrome. It plays a role as acute phase reactant [2–7].
As per in vitro studies intracellular ferritin sharply increases during maturation of monocytes to macrophages. In the phagocytic process of erythrocytes ferritin accumulate rapidly. Phagocytic macrophages are important source of serum ferritin and play central role in iron circulation. Therefore ferritin levels sharply increase in histiocytic proliferative disorders [8]. So it is taken as a useful indicator of disease activity both in neoplastic and reactive conditions.
There are four uncommon medical conditions characterized by high levels of ferritin, namely the macophage activation syndrome (MAS), adult onset still’s disease (AOSD), catastrophic antiphospholipid syndrome (cAPS) and septic shock, that share a similar clinical and laboratory features. Markedly elevated ferritin levels are associated with inflammatory conditions such as adult onset still’s disease (AOSD), Juvenile idiopathic arthritis and haemophagocytic lympho histiocytosis/MAS and septic shock [9].
Case Report
A 50 years old female was admitted to Fortis Hospital Shalimar Bagh with high fever, vomiting and breathing difficulty. Patient came with septic shock (procalcitonin levels—73.79 ng/ml). Numerous investigations were done with the relevant findings (Table 1). Biochemical investigations (Triglycerides, AST, ALT, LDH) were processed on Dimension RxL Max, Siemens, GERMANY. Serum ferritin and Procalcitonin levels were done with ECLIA methodology on Cobas e 411, Roche Diagnostics, Mannhemm Germany. Complete blood count was done by using fully automated hematology analyser Sysmex XT 1800i, USA. Fibrinogen levels were done on Star Compact Max, Diagnostica Stago platform via CLAUSS methodology. The diagnostic criteria include fever, splenomegaly, cytopenias affecting at least 2 of 3 lineages in the peripheral blood, hyperferritenemia greater than 10,000 ng/ml, hypertriglyceridemia and/or hypofibrinogenemia, hemophagocytosis in the bone marrow, spleen or lymph nodes, low or absent NK cell activity determined by 51cr release assay and high levels of sCD25. The authors have considered at least 5 out of 8 criteria to be positive for diagnosis of HLH. (Table 2) [10] Common laboratory findings of our patient include extremely high ferritin values (ferritin—119,191 ng/ml), elevated LDH (LDH—545 U/l), high CRP (>180 mg/l) and mild triglyceridemia (TG—284 mg/dl). For serum ferritin levels a cut off of 10,000 ng/ml was found to be 90 % sensitive and 96 % specific for HLH [11].
Table 1.
Laboratory findings of patient at the time of admission
| Parameter | Value | Units | Biological reference interval |
|---|---|---|---|
| Hb | 10.1 | g% | 12.0–15.0 |
| PT (mean—13.1) | 15.2 | secs | 11.4–13.7 |
| aPTT (mean—29.2) | 35.2 | secs | 27.8–41.8 |
| WBC | 37.2 × 109 | /l | 4.0–10.0 |
| Neutrophils | 89 × 109 | /l | 2.0–8.0 |
| Platelet | 218 | /cumm | 150–410 |
| AST | 81 | U/l | 15–37 |
| ALT | 91 | U/l | 30–65 |
| ALP | 176 | U/l | 50–136 |
| GGT | 155 | U/l | 5–85 |
| LDH | 545 | U/l | 81–234 |
| BUN | 27 | mg/dl | 5–20 |
| Creatinine | 2.8 | mg/dl | 0.6–1.1 |
| Triglycerides | 284 | mg/dl | <150—normal, 150–199—border line, >199 high |
| Fibrinogen | 517 | mg/dl | 200–400 |
| Ferritin | 119,191 | ng/ml | 10.0 291.0 |
| Procalcitonin | 73.79 | ng/ml | <0.5—low risk, >2.0 high risk |
| Leptospira | 0.74 | U/ml | <15.0–neg., 15–20 indeterminate, 20.0–positive |
| Complement C3 | 103 | mg/dl | 76–181 |
| Complement C4 | 56.5 | mg/dl | 14-52 |
| Sputum C/S | MRSA detected | No growth | |
| Hb variant analysis | Normal | Normal | |
| C-ANCA, P-ANCA | Negative | Negative | |
| Clostridium difficile toxin | Not detected | Not detected | |
| Myeloma band | Not detected | Not detected | |
| Bone marrow aspirate | Hemophagocytic lymphohistiocytosis | Normal |
Table 2.
Description of patient according to probable criteria of HLH
| Parameter | Criteria | Patient Detail |
|---|---|---|
| Fever | Non remitting high fever | Yes |
| Spleen | Enlarged | Yes (grade—++) |
| Neurologic symptoms | Present | Present |
| Medullar phagocytosis | Present | Present (grade—+) |
| Hemoglobin | <9.0 | 10.1 g% |
| Neutrophils | <1.0 × 109/l | 31.9 × 109/l |
| CRP | >90 mg/l | >180 mg/l |
| Fibrinogen | low | 517 mg/dl |
| Ferritin | >500 ng/ml | 119,191 ng/ml (grade—severe) |
| Triglycerides | High | 284 mg/dl (mild) |
| Peripheral smear | Cytopenia (2 of 3 lineages) | Normal |
| Bone marrow biopsy | Hemophagocytic syndrome | HLH (grade—+) |
Chest X ray showed bilateral fluffy shadows. Ultrasound report showed hepatomegaly and mild splenomegaly. Sputum culture was done which came positive for MRSA. Then bone marrow was done which confirmed hemophagocytic lymphohistiocytosis (Grade—+) and macrophage proliferation (Grade—++) ( Fig. 1). Histopathologic findings of HLH typically include a prominent and diffuse accumulation of lymphocytes and mature macrophages, which occasionally exhibit hemophagocytosis. The microscopic visualisation of hemophagocytosis is simply one of the possible diagnostic criteria [10].
Fig. 1.

Lymphocytic and macrophage proliferation with occasional haemophagocytosis (arrow)
Keeping everything in mind diagnosis of hemophagocytic lymphohistiocytosis was made. Course of IV steroid was started and patient showed marked improvement within 2 days. Patient became afebrile and showed fall in serum ferritin levels and was shifted to ward with discontinuation of steroid. Trend of serum ferritin levels during admission period is depicted (Chart—1).
After shifting to ward patient showed sign of deterioration along with fever and serum ferritin levels also started rising. Then patient had to shifted back to ICU and put on steroids again. Patient condition improved, became afebrile, showed fall in Serum Ferritin levels and shifted to wards after recovery. Patient became clinically better, tolerating oral diet, able to walk with support and decreasing trend of serum Ferritin levels. Finally patient was discharged with follow up medication mainly on steroids.
Discussion
Hyperferritinemia is an important lab indicator for infection triggered macrophage activation syndrome leading to HLH. HLH also known as hemophagocytic syndrome is an uncommon systemic inflammatory clinical syndrome associated with numerous conditions such as neoplastic, infectious, autoimmune or hereditary disease. HLH is caused by a defect in inflammatory signals that results in a setting of congenital or acquired defective natural killer (NK) T Cell function in the cytotoxic pathway [10].
In the present case patient presented with septic shock with extremely high ferritin value and elevated LDH. Bone marrow examination showed evidence of HLH with splenomegaly and hepatomegaly. Culture of sputum showed positivity for MRSA. Similar studies were done by other authors. During 7 months period Koduri et al. [12] studied four patients and diagnosed with RHPS. Of these three were diagnosed with acquired immunodeficiency syndrome. Their patient had elevated LDH (>1000 U/l), hyperferritinemia (range—34,976–425,984 ng/ml).
Four uncommon medical conditions characterized by high levels of ferritin namely MAS, AOSD, cAPS and septic shock that shows a similar clinical and laboratory features and also respond to similar treatments suggesting a common pathogenic mechanism [13]. In a study by Coffernils et al. [14] (1920) analyzed the scores of 40 patients with various severe inflammatory diseases aside from AOSD. No ferritin value was higher than 3300 ng/ml. In 3 of 10 consecutive patients ferritin value was higher than 3300 ng/ml. Among these three patients one patient showed a marked hyperferritinemia (3600 ng/ml)of mature appearing histiocytes and two patients had very high levels of serum ferritin (serum ferritin level—65,000 and 2,50,000 ng/ml). This study again suggest that very high serum ferritin levels encountered in AOSD reflect the presence of histiocytic hyperactivity that sometimes lead to HPS.
The clinical picture of MAS is generally acute and can be dramatic. Typically our patient was acutely ill with the sudden onset of non remitting high fever, splenomegaly. But leukocytes were raised in our case contrast to clinical feature of MAS. Elevated liver enzyme including AST, ALT, LDH, GGT, high concentration of triglycerides and low levels of sodium are observed. There is usually an abnormal coagulation profile (PT, aPTT and fibrinogen).
The disorder of HLH is characterized by histiocytic proliferation in bone marrow, liver and spleen. It shows hematopoetic cellular phagocytosis. This disorder usually includes familial type of HLH, sporadic type of HLH and infection associated HLH and fourth is MAS [15]. Infection associated HPS is a reactive process related with viral/bacterial/fungal/parasitic infections. It is usually seen due to cytokines effect leading to marrow depression and disturbed clotting parameters. Bone marrow shows normal to hypo cellular appearance with suppression of erythrocytes and myelopoiesis. Macrophages are markedly increased and shows phagocytosis. The disease is treated with controlling the underlying ineffective agents and steroid therapy. Out of so many criteria for diagnosing HLH hyperferritinemia is an important parameter. Not only in malignant and MAS condition but elevated serum ferritin levels are independently and positively associated with the presence of the metabolic syndrome [16] and are associated with single cardio vascular risk factor [17].
Conclusion
Measurement of serum ferritin levels may be used in diagnosis and can be a useful indicator of disease activity, Therapy response and prognosis related to HLH, AOSD, cAPS, sepsis, neoplasm and inflammatory conditions. Serum ferritin levels in histiocytic proliferative disorders is a useful indicator of disease activity both in neoplastic and reactive disorders.
The concept of hyperferritinemia is a major contributor to manage critically ill patients, for guiding therapy and predicting prognosis. It can be used as reflection of acute phase response in condition (MAS, AOSD, SS). These disorders share similar clinical finding and respond to similar treatment which suggest that hyper ferritinemia is involved in common pathogenic mechanism.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Compliance with Ethical Standards
Conflict of interest
Authors (Neelima, Jyoti, Pankaj, Alka, Leena and Manish) declare that they have no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Contributor Information
Neelima Verma, Email: drnilimaverma@gmail.com.
Jyoti chakraverty, Email: jyoti.chakraverty@srl.in.
Pankaj Baweja, Email: pankaj.baweja@srl.in.
Alka Girotra, Email: alka.girotra@srl.in.
Leena Chatterjee, Email: leena.chatterjee@srl.in.
Manish Chugh, Email: manish.chugh@srl.in.
References
- 1.Meyron-Holtz EG, Moshe-Belizowski S, Cohen LA. A possible role for secreted ferritin in tissue iron distribution. J Neural Transm. 2011;118(3):337–347. doi: 10.1007/s00702-011-0582-0. [DOI] [PubMed] [Google Scholar]
- 2.Mary AK, Jonathan AS, Lan GC, Suzy VT. Ferritin for the clinician. Blood Rev. 2009;23(3):95–104. doi: 10.1016/j.blre.2008.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Charles MJ, Michelle O, Howard F. Causes and significance of markedly elevated serum ferritin levels in an academic medical centre. J Clin Rheumatol. 2013;19(6):324–328. doi: 10.1097/RHU.0b013e31829ce01f. [DOI] [PubMed] [Google Scholar]
- 4.Prieto J, Barry M, Sherlock S. Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology. 1975;68:525–533. [PubMed] [Google Scholar]
- 5.Hershko C, Konijn AM. Serum ferritin in hematologic disorders. In: Albertini A, Arosio P, Chiancone E, Drysdale J, editors. Ferritins and isoferritins as biochemical markers. Amsterdam: Elsevier; 1984. 143–158 (Symposia of the Giovanni Lorenzini Foundation; 19).
- 6.Elin RJ, Wolff SM, Finch CA. Effect of induced fever on serum iron and ferritin concentrations in man. Blood. 1977;49:147–153. [PubMed] [Google Scholar]
- 7.Reissmann KR, Dietrich MR. On the presence of ferritin in the peripheral blood of patients with hepatocellular disease. J Clin Invest. 1956;35:588–595. doi: 10.1172/JCI103312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Eastham EJ, Bell JI, Douglas AP. Serum ferritin levels in acute hepatocellular damage from paracetamol overdosage. Br Med J. 1976;27:750–751. doi: 10.1136/bmj.1.6012.750-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Noriko E, Satoshi I, Shigeyoshi H, Shinjiro T, Shinsaku I. High serum ferritin level as a marker of malignant histiocytosis and virus associated hemophagocytic syndrome. Cancer. 1988;61:2071–2076. doi: 10.1002/1097-0142(19880515)61:10<2071::AID-CNCR2820611023>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
- 10.Rosado FGN, Kim AS. Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am J Clin Pathol. 2013;139:713–727. doi: 10.1309/AJCP4ZDKJ4ICOUAT. [DOI] [PubMed] [Google Scholar]
- 11.Allen CE, Yu X, Kozinetz CA, et al. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008;50:1227–1235. doi: 10.1002/pbc.21423. [DOI] [PubMed] [Google Scholar]
- 12.Koduri PR, Carandang G, DeMarais P, Patel AR. Hyperferritinemia in reactive hemophagocytic syndrome report of four adult cases. Am J Hematol. 1995;49(3):247–249. doi: 10.1002/ajh.2830490314. [DOI] [PubMed] [Google Scholar]
- 13.Cristina R, Jisele ZG, Esther GMH, David PDC, Yehuda S. The hyperferritinimic syndrome: macrophage activation syndrome, Still disease, septic coz and catastrophic anti phospholipid syndrome. BMC Med. 2013;11:185. doi: 10.1186/1741-7015-11-185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Coffernils M, Souport A, Pradier O, Feremon W. Hyperferritinemia in adult onset still’s disease and the hemophagocytic syndrome. J Rheumatol. 1992;19(9):1425–1427. [PubMed] [Google Scholar]
- 15.Singh T. Text book of hematology. 3. New Delhi: Arya Publishing House; 2014. [Google Scholar]
- 16.Victoria AU, Gemma FM, Rosa SA, Begona MK, Victoria A. Ferritin level and risk of metabolic syndrome: meta analysis of observational study. VMC Public Health. 2014;14:483. doi: 10.1186/1471-2458-14-483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Gade W, Schmit J, Collins M, Gada J. Beyond obesity: the diagnosis and pathophysiology of metabolic syndrome. Clin Lab Sci. 2010;23:51–61. [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
